Innovating antibodies, improving lives

Genmab is an international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer.

 

Dec 9 260x1732019 R&D Update and ASH Data Review 

Genmab will host its 2019 R&D Update and ASH Data Review on December 9 at 8:00 PM EST (2:00 AM CET / 1:00 AM GMT on December 10). The event will take place in the Hyatt Regency Orlando in Orlando, Florida, Bayhill 17-18. If you would like to attend in person you may register on site or click here to register in advance. The event will also be webcast live and you can click here to join the webcast. The webcast will be available to replay after the event via the same link.

This meeting is not an official program of the ASH Annual meeting.

 

join our team_260x173Career Opportunities at Genmab

Genmab is seeking new employees to join our team. Visit our Careers webpages to explore current vacancies, learn about our culture and meet some of our team members. Click here to visit Genmab's page on LinkedIn.    

 

 

Genmab 20 Years LogoCelebrating 20 Years

Genmab celebrates its 20th anniversary this year. We asked employees and external stakeholders for their perspectives on Genmab. Click here to watch the video and find out what they said.